Evidence map›Paper›PMID 24657375›Full record

ArticleJournal of health economics2014

Keep it simple? Predicting primary health care costs with clinical morbidity measures.

Samuel L Brilleman, Hugh Gravelle, Sandra Hollinghurst, Sarah Purdy, Chris Salisbury, Frank Windmeijer

Abstract read
In one paragraph

Article in Journal of health economics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Impact of multimorbidity on healthcare costs and utilisation: a systematic review of the UK literature.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021
    Pooled it
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Short- and intermediate-term impact of DTC telemedicine consultations on subsequent healthcare consumption.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Prevalence of suspected COVID-19 infection in patients from ethnic minority populations: a cross-sectional study in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2020
    Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samuel L BrillemanCentre for Academic Primary Care, University of Bristol, United Kingdom.
Hugh GravelleCentre for Health Economics, University of York, United Kingdom. Electronic address: hg8@york.ac.uk.
Sandra HollinghurstCentre for Academic Primary Care, University of Bristol, United Kingdom.
Sarah PurdyCentre for Academic Primary Care, University of Bristol, United Kingdom.
Chris SalisburyCentre for Academic Primary Care, University of Bristol, United Kingdom.
Frank WindmeijerDepartment of Economics, University of Bristol, United Kingdom.

Funding

Medical Research Council MR/K025643/1
6 · The paper itself

Abstract

Models of the determinants of individuals' primary care costs can be used to set capitation payments to providers and to test for horizontal equity. We compare the ability of eight measures of patient morbidity and multimorbidity to predict future primary care costs and examine capitation payments based on them. The measures were derived from four morbidity descriptive systems: 17 chronic diseases in the Quality and Outcomes Framework (QOF); 17 chronic diseases in the Charlson scheme; 114 Expanded Diagnosis Clusters (EDCs); and 68 Adjusted Clinical Groups (ACGs). These were applied to patient records of 86,100 individuals in 174 English practices. For a given disease description system, counts of diseases and sets of disease dummy variables had similar explanatory power. The EDC measures performed best followed by the QOF and ACG measures. The Charlson measures had the worst performance but still improved markedly on models containing only age, gender, deprivation and practice effects. Comparisons of predictive power for different morbidity measures were similar for linear and exponential models, but the relative predictive power of the models varied with the morbidity measure. Capitation payments for an individual patient vary considerably with the different morbidity measures included in the cost model. Even for the best fitting model large differences between expected cost and capitation for some types of patient suggest incentives for patient selection. Models with any of the morbidity measures show higher cost for more deprived patients but the positive effect of deprivation on cost was smaller in better fitting models.

Indexed as

AdultAgedAged, 80 and overAge DistributionCapitation FeeChronic DiseaseComorbidityDiagnosis-Related GroupsEnglandFemaleForecastingHealth Care CostsHumansMaleMiddle AgedPatient SelectionCapitationCostsHorizontal equityPrimary careRisk rating

Identifiers

PMID24657375
PMCPMC4051993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.